https://www.selleckchem.com/products/LBH-589.html
BACKGROUND Pegfilgrastim is available as a prefilled syringe (PFS) and an on-body injector (OBI). Whether the administration method of pegfilgrastim affects the effectiveness and health care resources has not been evaluated in the setting of routine care. OBJECTIVE To compare real-world clinical and economic outcomes between PFS and OBI methods of administration. METHODS This was a retrospective observational study in patients diagnosed with breast cancer or non-Hodgkin lymphoma who received myelosuppressive chemotherapy and prophylacti
Like
Comment
Share
